These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20868415)

  • 21. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
    Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
    AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
    Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
    Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
    AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis.
    Wang F; So Y; Vittinghoff E; Malani H; Reingold A; Lewis E; Giordano J; Janssen R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):75-82. PubMed ID: 8548350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic markers in AIDS-related cryptococcal meningitis.
    Majumder S; Mandal SK; Bandyopadhyay D
    J Assoc Physicians India; 2011 Mar; 59():152-4. PubMed ID: 21751623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
    Chetchotisakd P; Sungkanuparph S; Thinkhamrop B; Mootsikapun P; Boonyaprawit P
    HIV Med; 2004 May; 5(3):140-3. PubMed ID: 15139978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study.
    Oyella J; Meya D; Bajunirwe F; Kamya MR
    J Int AIDS Soc; 2012 Mar; 15(1):15. PubMed ID: 22417404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
    Park BJ; Wannemuehler KA; Marston BJ; Govender N; Pappas PG; Chiller TM
    AIDS; 2009 Feb; 23(4):525-30. PubMed ID: 19182676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptococcal meningitis in HIV-infected patients at Chiang Mai University Hospital: a retrospective study.
    Chaiwarith R; Vongsanim S; Supparatpinyo K
    Southeast Asian J Trop Med Public Health; 2014 May; 45(3):636-46. PubMed ID: 24974648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment.
    Ségéral O; Limsreng S; Nouhin J; Hak C; Ngin S; De Lavaissière M; Goujard C; Taburet AM; Nerrienet E; Delfraissy JF; Ouk V; Dulioust A
    AIDS Res Hum Retroviruses; 2011 Jun; 27(6):597-603. PubMed ID: 21083413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.